Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Trading Down 0.0 %
The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The business has a fifty day moving average price of $22.00 and a 200 day moving average price of $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- United Airlines Soars on Earnings Beat
- 3 Stocks to Consider Buying in October
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Learn Technical Analysis Skills to Master the Stock Market
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
